Lypanosys - Contact Us
Lypanosys is a drug development company developing a clinically differentiated drug for the rapidly growing and under-served Dermatology market. Lypanosys initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. Atopic dermatitis AD is the most common chronic inflammatory skin disease of childhood and a not uncommon condition in adults. In the US alone there are 30 million AD sufferers. That will differentiate it from other competitive offerings46.
OVERVIEW
The site lypanosys.com currently has an average traffic ranking of zero (the smaller the more traffic). We have traversed zero pages within the site lypanosys.com and found two websites linking to lypanosys.com. There are two contacts and addresses for lypanosys.com to help you correspond with them. The site lypanosys.com has been on the internet for eight hundred and five weeks, five days, eleven hours, and fifty-six minutes.
Links to this site
2Contacts
2Addresses
2Online Since
Jan 2009LYPANOSYS.COM TRAFFIC
The site lypanosys.com has seen a variation amounts of traffic all over the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LYPANOSYS.COM HISTORY
The site lypanosys.com was created on January 18, 2009. It was changed on the date of December 08, 2013. This domain will go back on the market on January 18, 2015. It is now eight hundred and five weeks, five days, eleven hours, and fifty-six minutes old.
REGISTERED
January
2009
UPDATED
December
2013
EXPIRED
January
2015
SPAN
15
YEARS
5
MONTHS
6
DAYS
LINKS TO WEBSITE
Nz Angel Investors Helping Start Ups Succeed FKA NZ
Angel investors that charge no commission and have a genuine. Interest in helping entrepreneurs grow their businesses. Startup businesses propel us into the future. Let FKA be the fuel that helps drive your business success. Knowledge, experience and connections. We take pride in our comprehensive due diligence on your business model,.
WHAT DOES LYPANOSYS.COM LOOK LIKE?
CONTACTS
Meracol Corporation
Tony Bishop
P.O Box 113072 Newmarket
Auckland, N/A, na
NEW ZEALAND
Domain Agent
Daniel Williams
PO Box 302 829 North Harbour
Auckland, NONE, 1311
NEW ZEALAND
LYPANOSYS.COM SERVER
We detected that a single page on lypanosys.com took two thousand three hundred and seventy-seven milliseconds to stream. We discovered a SSL certificate, so our crawlers consider this site secure.
Load time
2.377 sec
SSL
SECURE
IP
128.199.107.41
NAME SERVERS
ns1.nameserver.net.nz
ns2.nameserver.net.nz
ns3.nameserver.net.nz
WEBSITE ICON
SERVER SOFTWARE
We discovered that this website is using the Apache/2.4.7 (Ubuntu) server.SITE TITLE
Lypanosys - Contact UsDESCRIPTION
Lypanosys is a drug development company developing a clinically differentiated drug for the rapidly growing and under-served Dermatology market. Lypanosys initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. Atopic dermatitis AD is the most common chronic inflammatory skin disease of childhood and a not uncommon condition in adults. In the US alone there are 30 million AD sufferers. That will differentiate it from other competitive offerings46.PARSED CONTENT
The site lypanosys.com has the following on the site, "Lypanosys is a drug development company developing a clinically differentiated drug for the rapidly growing and under-served Dermatology market." I noticed that the website also said " Lypanosys initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis." They also stated " Atopic dermatitis AD is the most common chronic inflammatory skin disease of childhood and a not uncommon condition in adults. In the US alone there are 30 million AD sufferers. That will differentiate it from other competitive offerings46."ANALYZE MORE WEBSITES
lypartners.com
Welcome to the home of lypartners. To change this page, upload your website into the public html directory.
洛阳市人民代表大会常务委员会网站
关于对 关于开通 六组团 公交车的议案 审议结果的.